HomeBooksAboutSubscribe
Longevity Science

NAD+ and Cellular Energy: What the Research Shows

September 2026 · 9 min read · By Mark Holshouser
Evidence checked September 13, 2026

How does NAD+ support cellular energy?

NAD+ is an electron-accepting coenzyme that becomes NADH during fuel breakdown. NADH carries reducing equivalents that can support mitochondrial electron transport and ATP production through oxidative phosphorylation. Glycolysis and the TCA cycle also produce ATP or GTP through substrate-level phosphorylation. Recycling NADH to NAD+ helps sustain metabolic flux, but this established biochemistry does not show that raising NAD+ necessarily improves human energy, performance, or health.[1][5]

NAD+/NADH: electron transfer, not an energy supplement claim

Cells convert chemical energy from nutrients into forms they can use. ATP supports work such as muscle contraction, molecular transport, and biosynthesis. NAD+ has a different job: it helps enzymes transfer electrons during oxidation-reduction, or redox, reactions. Oxidation means losing electrons; reduction means gaining them.

In many dehydrogenase reactions, NAD+ accepts a hydride equivalent: two electrons and one proton. It becomes NADH, the reduced form. “Reducing equivalents” describes the electron-carrying capacity that NADH can pass onward. NADH is therefore not ATP, and NAD+ is not a fuel like glucose. They participate in reactions that extract and transfer energy from fuels.[1]

NAD+ and NADH are continually interconverted during redox metabolism rather than used once and discarded. Other enzymes consume NAD+ for signaling and repair-related reactions, so synthesis and salvage also matter. For that broader biology, see What Is NAD+?. Here, the focus is the electron-transfer sequence from fuel breakdown to ATP formation.

Glycolysis: cytosolic ATP and the need to regenerate NAD+

Glycolysis breaks glucose down to pyruvate in the cytosol, the fluid portion of the cell outside organelles. At the glyceraldehyde-3-phosphate dehydrogenase step, NAD+ accepts electrons and becomes NADH. Subsequent reactions transfer phosphate directly from metabolic intermediates to ADP, making ATP. That direct transfer is called substrate-level phosphorylation; it does not require an electron transport chain.[4]

Glycolysis needs a continuing supply of oxidized NAD+. If NADH accumulates without being reoxidized, the NAD+-dependent reaction cannot keep running freely. One route for regeneration is lactate dehydrogenase: pyruvate is reduced to lactate while NADH is oxidized back to NAD+. This reaction does not itself make ATP, but it allows glycolytic ATP production to continue.

Lactate production is not restricted to a complete absence of oxygen. Cells can use it when glycolytic demand and mitochondrial processing are differently balanced.[9] Red blood cells, which lack mitochondria, illustrate why “all ATP comes from mitochondria” is wrong: their ATP depends on glycolysis. In cells with mitochondria, cytosolic electron shuttles provide another way to reoxidize glycolytic NADH.[4]

Pyruvate oxidation and the TCA cycle

When pyruvate enters mitochondria for oxidation, the pyruvate dehydrogenase complex converts it into acetyl-CoA. Carbon dioxide is released, and NAD+ is reduced to NADH. This links glycolysis to the tricarboxylic acid cycle, also called the TCA or citric acid cycle. Pyruvate oxidation generates reducing equivalents, not ATP directly.[6]

Acetyl-CoA enters the TCA cycle by combining with oxaloacetate. Through a sequence of reactions, carbon is released as carbon dioxide and oxaloacetate is regenerated. Several steps reduce NAD+ to NADH; another involves FAD-dependent electron transfer. In mammalian cells, most cycle reactions occur in the mitochondrial matrix, while succinate dehydrogenase is embedded in the inner membrane.

The cycle also includes substrate-level phosphorylation at the succinyl-CoA synthetase step. Depending on the mammalian enzyme form, this produces GTP or ATP.[7] GTP can support ATP formation through a separate nucleoside-diphosphate kinase reaction that transfers phosphate to ADP. This direct nucleotide production is separate from the larger downstream contribution of reducing equivalents to oxidative phosphorylation.[5][6]

The TCA cycle is not an isolated conveyor operating at a fixed speed. Its intermediates also support biosynthesis, and other reactions replenish them. Fuel supply, enzyme regulation, energy demand, and the local NAD+/NADH balance all influence its operation. More of one coenzyme does not automatically accelerate the entire system.

Oxidative phosphorylation: redox energy drives a proton gradient

In the mitochondrial matrix, NADH donates electrons to complex I of the electron transport chain and is reoxidized to NAD+. Electrons then pass through carriers toward oxygen, the final electron acceptor, which is reduced to water. Electron transfer releases energy that supports proton pumping across the inner mitochondrial membrane.[5]

This creates an electrochemical gradient: both a charge difference and a proton concentration difference. ATP synthase uses proton flow back toward the matrix to make ATP from ADP and inorganic phosphate. Electron transport and ATP synthesis are coupled through this gradient, rather than NADH directly handing a phosphate to ADP.

Oxidative phosphorylation supplies much of the ATP in many oxygen-using cells, but its contribution varies with cell type and conditions. Glycolytic and TCA substrate-level phosphorylation still count. A universal ATP yield per glucose would hide differences in shuttles, membrane leak, and transport costs, so no fixed total is needed to explain the mechanism.

If electron transport is constrained, mitochondrial NADH can accumulate and NAD+ regeneration can slow. That can feed back onto NAD+-dependent fuel oxidation. Conversely, functioning respiration also needs oxygen, suitable substrates, ADP, phosphate, and an effective membrane gradient. NAD+ availability is one part of this coordinated process, not an independent control for ATP output.[5]

Cytosolic and mitochondrial pools: what shuttles actually move

A cell does not have one uniformly mixed NAD pool. Cytosolic and mitochondrial NAD+/NADH pools can have different concentrations and redox balances. The inner mitochondrial membrane prevents free equilibration, so cytosolic NADH does not simply diffuse into the matrix. Whole-cell measurements can conceal a change within one compartment.[1][2]

The malate-aspartate shuttle transfers reducing equivalents through coupled reactions and metabolite transport. Cytosolic NADH helps reduce oxaloacetate to malate. After transport, malate oxidation produces NADH in the matrix; linked reactions and transport complete the cycle. The net result transfers reducing power, not the original NADH molecule, across the compartment boundary.[1]

The glycerol-3-phosphate shuttle also regenerates cytosolic NAD+. It transfers electrons through glycerol-3-phosphate and a mitochondrial FAD-dependent enzyme to the ubiquinone pool of the respiratory chain. It does not generate matrix NADH by the same route as the malate-aspartate shuttle. Which shuttle contributes depends on tissue and metabolic context.[8]

Electron shuttling should not be confused with replenishing mitochondrial NAD+ itself. Luongo and colleagues identified SLC25A51 as a mammalian mitochondrial NAD+ transporter. Their laboratory experiments supported uptake of intact NAD+ and showed that disrupting this transporter could lower mitochondrial NAD+ without lowering whole-cell NAD+. That identifies a transport mechanism, not a demonstrated human energy-boosting intervention.[2]

Evidence and uncertainty: metabolic necessity is not clinical efficacy

Metabolic flux means the rate at which material moves through a pathway. NAD+ availability and the NAD+/NADH balance affect enzyme reactions and their thermodynamic favorability. An inadequate oxidized pool can constrain flux. But a larger total pool does not necessarily mean a more favorable redox balance, faster respiration, or greater ATP production.[1]

Pool size, redox balance, and flux answer different questions. Pool size asks how much coenzyme is present. Redox balance asks how it is distributed between oxidized and reduced forms in a particular compartment. Flux asks how quickly reactions proceed. Measuring one cannot substitute for measuring the others. A steady ATP concentration also does not reveal how rapidly ATP is being produced and used.

This distinction helps explain why a laboratory finding can be important without establishing a treatment benefit. Restoring a specifically disrupted transport mechanism in experimental cells tests that mechanism. Giving a precursor to people tests a different exposure in a far more complex setting. Neither experiment should be described as answering the other's question.

These mechanisms are established biochemistry. Whether an intervention improves a person's fatigue, physical performance, or health is a different question requiring human trials with relevant outcomes. A blood NAD measurement is not a direct measurement of mitochondrial NAD, ATP synthesis, or how energetic someone feels.

Damgaard and Treebak's 2023 review of human nicotinamide riboside studies reported few clinically relevant effects overall despite biochemical changes in the literature. It evaluates NR evidence available then, not every NAD-related intervention or later trial. It supports caution, not a claim that benefit is impossible.[3] For the separate age-related evidence, read NAD+ decline with age.

Five questions about NAD+ and cellular energy

1. Is NADH the same thing as ATP?

No. NADH carries reducing equivalents, while ATP supports cellular work through phosphate-transfer reactions and related processes. NADH oxidation can help power ATP synthesis, but the two molecules have different chemical roles.

2. Does all ATP production require oxidative phosphorylation?

No. Glycolysis makes ATP through substrate-level phosphorylation in the cytosol. The TCA cycle also produces ATP or GTP directly. Oxidative phosphorylation is a separate process using electron transport, a proton gradient, and ATP synthase.

3. Why does glycolysis need NAD+ if it can run without oxygen?

A glycolytic oxidation step needs NAD+ as an electron acceptor regardless of oxygen availability. Converting pyruvate to lactate regenerates NAD+ from NADH, allowing that step and the pathway's substrate-level ATP production to continue.

4. Does cytosolic NADH enter mitochondria directly?

It does not freely cross the inner mitochondrial membrane. Shuttles transfer its reducing equivalents through other molecules and reactions. Transport of intact NAD+ through SLC25A51 is a distinct process that helps maintain the mitochondrial coenzyme pool.

5. Would raising NAD+ necessarily make someone feel more energetic?

No. NAD+ is necessary for metabolism, but necessity does not prove that increasing it improves symptoms or performance. Compartment, redox balance, other metabolic constraints, and measured human outcomes matter more than a biochemical change alone.

Read the evidence in context

NAD+ redox chemistry and MOTS-c signaling are different biological topics. The NAD+ vs MOTS-c comparison explains that distinction. For a book-length examination of mechanisms and evidence limits, explore NAD+ vs MOTS-c: The Honest Comparison.

Explore more evidence-based explanations in all articles.

References

  1. Covarrubias AJ, Perrone R, Grozio A, Verdin E. “NAD+ metabolism and its roles in cellular processes during ageing.” Nature Reviews Molecular Cell Biology, 2021;22:119–141. doi:10.1038/s41580-020-00313-x ↗
  2. Luongo TS, et al. “SLC25A51 is a mammalian mitochondrial NAD+ transporter.” Nature, 2020;588:174–179. doi:10.1038/s41586-020-2741-7 ↗
  3. Damgaard MV, Treebak JT. “What is really known about the effects of nicotinamide riboside supplementation in humans.” Science Advances, 2023;9:eadi4862. doi:10.1126/sciadv.adi4862 ↗
  4. Chaudhry R, Varacallo MA. “Biochemistry, Glycolysis.” StatPearls, updated August 8, 2023. NCBI Bookshelf ↗
  5. Cooper GM. “The Mechanism of Oxidative Phosphorylation.” The Cell: A Molecular Approach, 2nd edition. Sinauer Associates, 2000. NCBI Bookshelf ↗
  6. Ahmad M, Wolberg A, Kahwaji CI. “Biochemistry, Electron Transport Chain.” StatPearls, updated September 4, 2023. NCBI Bookshelf ↗
  7. Lambeth DO, Tews KN, Adkins S, Fröhlich D, Milavetz BI. “Expression of two succinyl-CoA synthetases with different nucleotide specificities in mammalian tissues.” Journal of Biological Chemistry, 2004;279:36621–36624. doi:10.1074/jbc.M406884200 ↗
  8. Dhoundiyal A, Goeschl V, Boehm S, Kubista H, Hotka M. “Glycerol-3-Phosphate Shuttle Is a Backup System Securing Metabolic Flexibility in Neurons.” Journal of Neuroscience, 2022;42:7339–7354. doi:10.1523/JNEUROSCI.0193-22.2022 ↗
  9. Brooks GA. “Cell–cell and intracellular lactate shuttles.” The Journal of Physiology, 2009;587:5591–5600. doi:10.1113/jphysiol.2009.178350 ↗

This article is for educational purposes and is not medical advice.

Mark Holshouser
Author bio →
← Back to all articles